View in EDS HTML Full Text PDF Full Text

A randomized controlled, open‐label early phase II trial comparing incidence of FOLFIRI.3‐induced diarrhoea between Hangeshashinto and oral alkalization in Japanese patients with colorectal cancer.

Saved in:

Bibliographic Details
Title:	A randomized controlled, open‐label early phase II trial comparing incidence of FOLFIRI.3‐induced diarrhoea between Hangeshashinto and oral alkalization in Japanese patients with colorectal cancer.
Authors:	Yamazaki, Kaori¹ yamazakika@chiba-u.jp, Ariyoshi, Noritaka¹, Miyauchi, Hideaki², Ohira, Gaku², Kaneya, Noriko¹, Yamamoto, Kohei¹, Arai, Kenichi¹, Yamazaki, Shingo¹, Matsubara, Hisahiro², Suzuki, Takaaki¹, Ishii, Itsuko¹
Source:	Journal of Clinical Pharmacy & Therapeutics. Dec2019, Vol. 44 Issue 6, p946-951. 6p.
Database:	Academic Search Ultimate
Full text is not displayed to guests. Login for full access.

Description
ISSN:	02694727
DOI:	10.1111/jcpt.13020